Filing Details
- Accession Number:
- 0001237899-12-000080
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-15 17:12:23
- Reporting Period:
- 2012-11-13
- Filing Date:
- 2012-11-15
- Accepted Time:
- 2012-11-15 17:12:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1226435 | A Murray Goldberg | 777 Old Saw Mill River Road Tarrytown NY 10591 | Svp Finance And Admin Cfo Trea | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-11-13 | 4,745 | $65.76 | 95,259 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-11-13 | 2,128 | $146.60 | 93,131 | No | 4 | F | Direct | |
Common Stock | Disposition | 2012-11-13 | 1,205 | $146.60 | 91,926 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2012-11-13 | 3,431 | $8.50 | 95,357 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-11-13 | 198 | $146.60 | 95,159 | No | 4 | F | Direct | |
Common Stock | Disposition | 2012-11-13 | 1,489 | $146.60 | 93,670 | No | 4 | F | Direct | |
Common Stock | Disposition | 2012-11-13 | 200 | $144.36 | 93,470 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-11-13 | 300 | $145.65 | 93,170 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-11-13 | 1,400 | $146.58 | 91,770 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-11-13 | 3,845 | $147.62 | 87,925 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-11-13 | 792 | $148.05 | 87,133 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-11-14 | 1,556 | $147.65 | 85,577 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-11-14 | 900 | $148.65 | 84,677 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-11-14 | 700 | $149.18 | 83,977 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-11-13 | 3,431 | $0.00 | 3,431 | $8.50 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-11-13 | 4,745 | $0.00 | 4,745 | $65.76 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2012-12-20 | No | 4 | M | Direct | |
0 | 2011-09-06 | 2012-12-20 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 5,560 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 300 shares of Company stock on November 13, 2012 at prices ranging from $145.47 to $145.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 13, 2012 at each separate price.
- Represents volume-weighted average price of sales of 1,400 shares of Company stock on November 13, 2012 at prices ranging from $146.00 to $146.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 13, 2012 at each separate price.
- Represents volume-weighted average price of sales of 3,845 shares of Company stock on November 13, 2012 at prices ranging from $147.00 to $147.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 13, 2012 at each separate price.
- Represents volume-weighted average price of sales of 792 shares of Company stock on November 13, 2012 at prices ranging from $148.00 to $148.12. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 13, 2012 at each separate price.
- Represents volume-weighted average price of sales of 1,556 shares of Company stock on November 14, 2012 at prices ranging from $147.27 to $147.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2012 at each separate price.
- Represents volume-weighted average price of sales of 900 shares of Company stock on November 14, 2012 at prices ranging from $148.19 to $148.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2012 at each separate price.
- Represents volume-weighted average price of sales of 700 shares of Company stock on November 14, 2012 at prices ranging from $149.04 to $149.54. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2012 at each separate price.
- The option became exercisable with respect to all shares underlying the option upon the satisfaction by the company of certain performance criteria on February 10, 2012.
- Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.